Does ADALIMUMAB-AATY Cause Therapy interrupted? 88 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 88 reports of Therapy interrupted have been filed in association with ADALIMUMAB-AATY (Yuflyma). This represents 5.2% of all adverse event reports for ADALIMUMAB-AATY.
88
Reports of Therapy interrupted with ADALIMUMAB-AATY
5.2%
of all ADALIMUMAB-AATY reports
0
Deaths
19
Hospitalizations
How Dangerous Is Therapy interrupted From ADALIMUMAB-AATY?
Of the 88 reports, 19 (21.6%) required hospitalization, and 2 (2.3%) were considered life-threatening.
Is Therapy interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB-AATY. However, 88 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB-AATY Cause?
Intentional dose omission (338)
Drug ineffective (151)
Intentional product use issue (151)
Death (132)
Arthralgia (96)
Rheumatoid arthritis (94)
Fatigue (92)
Crohn's disease (87)
Headache (86)
Accidental exposure to product (85)
What Other Drugs Cause Therapy interrupted?
ADALIMUMAB (5,755)
ETANERCEPT (3,397)
RELUGOLIX (3,251)
CERTOLIZUMAB PEGOL (3,209)
LENALIDOMIDE (2,724)
UPADACITINIB (1,741)
ABATACEPT (1,726)
CLOZAPINE (1,722)
AMIKACIN (1,283)
TOFACITINIB (1,182)
Which ADALIMUMAB-AATY Alternatives Have Lower Therapy interrupted Risk?
ADALIMUMAB-AATY vs ADALIMUMAB-ADAZ
ADALIMUMAB-AATY vs ADALIMUMAB-ADBM
ADALIMUMAB-AATY vs ADALIMUMAB-AFZB
ADALIMUMAB-AATY vs ADALIMUMAB-ATTO
ADALIMUMAB-AATY vs ADALIMUMAB-BWWD